New pharmacologic approaches to double athetosis.
D000293:Adolescent; D000328:Adult; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001264:Athetosis / Q000188:drug therapy*; D001552:Benzazepines / Q000627:therapeutic use; D001593:Benzyl Compounds / Q000627:therapeutic use; D003975:Diazepam / Q000627:therapeutic use; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D005260:Female; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D007659:Ketones / Q000627:therapeutic use; D009574:Nitro Compounds / Q000627:therapeutic use; D012694:Serine / Q000627:therapeutic use
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001552:Benzazepines; D001593:Benzyl Compounds; D006834:Hydrazines; D007659:Ketones; D009574:Nitro Compounds; D012694:Serine; D004295:Dihydroxyphenylalanine; D006220:Haloperidol; D003975:Diazepam